RE:RE:How low will it go? CEO and Chairman have been silent too long. They need to address shareholders pronto regarding the sinking share price. Fundamentals of the company did not change for over 5 years, if anything, they improved....they've been saying their product is superior than their competitors (the science backs it up)....they have FDA approval to go into clinic and a robust pipeline....yet, the share price is at historical lows. If all of the above is correct, it's unfathomable that a deal wasn't struck years ago with pharma to get the clinical trials done in a timely manner if in the end the ultimate goal is/was really to help people stricken with this horrible disease